Genelex Offers New Specialty Genes, Panels
Genelex has expanded its test and panel offering with new specialty items tailored to cardiologists and psychiatrists. Genelex now offers:
New individual tests:
- Factor V (Leiden) and Factor II
New specialty panels:
- Cardiology Panel (which includes Factor II, Factor V, and MTHFR)
- Psychiatry Panel (which includes MTHFR and 5HTT/SLC6A4)
New rush processing:
Simplified results (without medication list review) will be delivered in 2 business days
- Clopidogrel (Plavix) STAT (CYP2C19)
- Warfarin STAT (CYP2C9 and VKORC1)
The MTHFR enzyme affects vitamin B synthesis, is associated with certain cardiac and psychological conditions, and can affect drug metabolism. Factor V and II are blood clotting proteins that influence a patient’s risk of thrombosis. These, combined with the new rush processing on clopidogrel and warfarin tests, should help ensure the safety of your patient’s cardiology regimen.
Prescribers who are initiating these therapies should consider examining Genelex’s new options. To learn more about pharmacogenetic testing, please go to http://youscript.com/healthcare-professionals/what-is-youscript/pharmacogenetic-testing/.
Take a Risk Assessment
Simply enter the medications you’re currently on or plan to take. Click “Get Results” to see if your regimen puts you at risk for an adverse drug reaction.
YOUR GENELEX RISK ASSESSMENT RESULTS: